Sunday, May 29, 2016

Image Comics Announces Return of "Casanova: Acedia"


CASANOVA: ACEDIA CELEBRATES TEN YEARS

Issue #5 begins an all-new story arc in the beloved, fan-favorite series

Bestselling creators Matt Fraction (SEX CRIMINALS, ODY-C), Michael Chabon (The Amazing Adventures of Kavalier & Clay), Gabriel Bá and Fábio Moon (Daytripper) return for an all-new story arc this June.

CASANOVA: ACEDIA #5 begins a new chapter in the fan-favorite series as the world-melting CASANOVA returns. Casanova Quinn doesn’t remember who he is or how he got here—the only thing he knows is an awful lot of people want him dead and the world might be ending.

Psychedelic, sexy, and surreal science-fiction abounds and sees the continuation of Pulitzer prize-winning author Michael Chabon's Metanaut backup collaborations with Gabriel Bá. The series celebrates ten trippy years of adventures with fans.

CASANOVA: ACEDIA #5 Cover A (Diamond Code APR160677) and Cover B (Diamond Code MAR168905) hit stores on Wednesday, June 1, 2016.

CASANOVA: ACEDIA, VOL. 1 (ISBN: 978-1632154774), is available now. It can be ordered by retailers from Diamond Book Distributors with Diamond Code: AUG150556 or on Amazon, Barnes & Noble, Indiebound, and Indigo.


ABOUT IMAGE COMICS
Image Comics is a comic book and graphic novel publisher founded in 1992 by a collective of best-selling artists. Image has since gone on to become one of the largest comics publishers in the United States. Image currently has five partners: Robert Kirkman, Erik Larsen, Todd McFarlane, Marc Silvestri and Jim Valentino. It consists of five major houses: Todd McFarlane Productions, Top Cow Productions, Shadowline, Skybound and Image Central. Image publishes comics and graphic novels in nearly every genre, sub-genre, and style imaginable. It offers science fiction, fantasy, romance, horror, crime fiction, historical fiction, humor and more by the finest artists and writers working in the medium today. For more information, visit www.imagecomics.com.

-------------------

No comments:

Post a Comment